Literature DB >> 10663411

An atypical compound by any other name is still a.

H Y Meltzer1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10663411     DOI: 10.1007/s002130050018

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  Prolactin secretion is not a core dimension of "atypicality".

Authors:  Gerhard Gründer; Otto Benkert
Journal:  Psychopharmacology (Berl)       Date:  2002-06       Impact factor: 4.530

2.  Second generation antipsychotics.

Authors:  W Wolfgang Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  2002-06       Impact factor: 4.530

Review 3.  Is rational antipsychotic polytherapy feasible? A selective review.

Authors:  Rune Andreas Kroken; Erik Johnsen
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 4.  The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Authors:  Gerhard Gründer; Hanns Hippius; Arvid Carlsson
Journal:  Nat Rev Drug Discov       Date:  2009-02-13       Impact factor: 84.694

5.  Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database.

Authors:  Kangyuan Guo; Zhanchun Feng; Shanquan Chen; Ziqi Yan; Zhiming Jiao; Da Feng
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 6.  Are second generation antipsychotics a distinct class?

Authors:  Caroline Bonham; Christopher Abbott
Journal:  J Psychiatr Pract       Date:  2008-07       Impact factor: 1.325

7.  PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS.

Authors:  V P Matei; T Purnichi; A Mihailescu; R Grigoras
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

8.  A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS.

Authors:  Dan Liu; Zhuoling An; Pengfei Li; Yanhua Chen; Ruiping Zhang; Lihong Liu; Jiuming He; Zeper Abliz
Journal:  RSC Adv       Date:  2020-05-13       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.